Related Experiment Video
Updated: May 23, 2025

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Ingenane Diterpenoids from Euphorbia peplus as Potential New CHK1 Inhibitors That Sensitize Cancer Cells to
Mi Zhou1,2, Yanlan Yang1, Shoulun He1
1School of Pharmaceutical Science, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361002, China.
Abstract:
Phosphorylation of checkpoint kinase 1 at Ser-345 (p-CHK1(S345)) mediates the replication stress response in cancer cells, leading to chemotherapy resistance. Therefore, finding inhibitors of p-CHK1(S345) is currently a promising strategy to prevent acquired drug resistance. In this study, 14 ingenane diterpenoids (1-14), involving two undescribed compounds possessing an unprecedented exocyclic double bond Δ6(20), were identified from Euphorbia peplus. The inhibitory effects of the isolated compounds on p-CHK1(S345) and their structure-activity relationship (SAR) were investigated. Compounds 7 and 8 presented the strongest inhibitory effects, abrogated cell cycle arrest, and caused the accumulation of DNA damage, improving the sensitivity of cancer cells to chemotherapeutic drugs. An in vivo assay confirmed the enhancement of 8 on the anticancer effect of topotecan via blocking of p-CHK1(S345). Mechanistically, 8 increased CHK1 ubiquitination to inhibit p-CHK1(S345) via activation of protein kinase C (PKC). PKC activation was first found to enhance CHK1 ubiquitination to block p-CHK1(S345). Above all, this finding not only indicates that compound 8 could be developed as a novel CHK1 inhibitor but also reveals a previously unrecognized role of PKC in regulating cancer chemotherapy sensitivity.
Insights
Two new compounds from Euphorbia peplus inhibit p-CHK1(S345), a key factor in chemotherapy resistance. Compound 8 enhances cancer drug efficacy by blocking this target, offering a novel therapeutic strategy.
Area of Science:
- Natural Products Chemistry
- Cancer Biology
- Pharmacology
Background:
- Phosphorylation of checkpoint kinase 1 (p-CHK1(S345)) is crucial for the replication stress response in cancer, contributing to chemotherapy resistance.
- Developing inhibitors of p-CHK1(S345) is a key strategy to overcome acquired drug resistance in cancer therapy.
Purpose of the Study:
- To identify and characterize novel inhibitors of p-CHK1(S345) from Euphorbia peplus.
- To investigate the structure-activity relationship (SAR) of ingenane diterpenoids against p-CHK1(S345).
- To explore the potential of identified compounds in enhancing cancer chemotherapy sensitivity.
Main Methods:
- Isolation and structural elucidation of 14 ingenane diterpenoids from Euphorbia peplus, including two novel compounds.
- In vitro screening of isolated compounds for inhibitory effects on p-CHK1(S345).
- In vivo evaluation of compound 8 in combination with topotecan.
- Mechanistic studies involving CHK1 ubiquitination and protein kinase C (PKC) activation.
Main Results:
- Two undescribed ingenane diterpenoids with an exocyclic double bond were identified.
- Compounds 7 and 8 exhibited potent inhibition of p-CHK1(S345), abrogated cell cycle arrest, and increased DNA damage.
- Compound 8 enhanced the anticancer efficacy of topotecan in vivo by blocking p-CHK1(S345).
- Compound 8 promotes CHK1 ubiquitination and inhibits p-CHK1(S345) through PKC activation.
Conclusions:
- Compound 8 demonstrates potential as a novel CHK1 inhibitor for cancer therapy.
- PKC activation plays a previously unrecognized role in enhancing cancer chemotherapy sensitivity by regulating CHK1 ubiquitination.
- This study provides a new therapeutic avenue targeting the p-CHK1(S345) pathway and PKC signaling.
More Related Videos
Related Concept Videos
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Physical Properties of Amines
Amines: Introduction
Nomenclature of Alkynes
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Nomenclature of Aryl and Heterocyclic Amines

